+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Regenerative Medicine Market Set to Register 12.8% CAGR due to Rising Tissue Engineering and Stem Cell Therapy

Posted on Sep 09, 2015

According to Transparency Market Research’s new market research report, titled ‘Regenerative Medicine Market  - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, the global regenerative medicine market is driven by several technological advancements in stem cell therapy and tissue engineering therapy. Such growth factors are expected to push the market from a value of US$2.6 billion in 2012 to US$6.5 billion by 2019. Overall, the market is expected to grow at a CAGR of 12.8% from 2013 to 2019.  

Browse the full Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/regenerative-medicines-market.html

The study report provides a complete snapshot of the global regenerative medicine market by technology, applications, and geography for the forecast period from 2012 to 2019. Under the overview section, the study defines regenerative medicine as a solution to regenerate, repair, or replace damaged tissue and organs in the body. Regenerative medicine is an emerging field of medical science and has wide areas of application such as musculoskeletal diseases, cardiovascular, neurology, orthopedic, and disorders. Besides technological advancements in the global regenerative medicine market, the growing prevalence of bone and joint disorders has also increased demand from the regenerative medicine market rapidly across the globe. This factor has substantially propelled the global regenerative medicine (bone and joint) market.  


Based on technology, the global market for regenerative medicine is segmented as stem cell therapy, biomaterials, and tissue engineering. The report states that in 2012, due to the favorable reimbursement policies and strong demand for biomaterials, the biomaterials segment took up the largest share of the global regenerative medicine (bone and joint) market. However, according to the studies, high cost associated with biomaterials will be a major factor expected to restrict the global regenerative medicine market over the forecast period. In addition, tissue engineering is expected to grow at a rapid pace until 2019. Growth of this segment is expected to occur at the highest CAGR from 2013 to 2019. 

 


By applications, the global market for regenerative medicine (bone and joint) is segmented into allogeneic bones, bone graft substitute, autogenic bones, osteoarticular diseases, and others. Owing to increasing demand for bone graft substitutes in orthopedic surgeries, the bone graft substitutes segment held the largest share of the global regenerative medicine market in 2012. TMR analysts state that post-implantation rejection associated with bone graft substitute methods is considered to be a key factor that would restrict the demand for bone graft substitutes across various regions.   


Moreover, the study report enlists some of the major market players in the global regenerative medicine (bone and joint) market. These include Medtronic, Inc. (INFUSE Bone Graft), Zimmer Holdings, Inc., Orthofix, Inc. (Trinity Evolution), DePuy Synthes, Inc., and NuVasive, Inc. (Osteocel Plus).Many of the companies operating in the regenerative medicine market focus on investing in the emerging economies in Asia Pacific, such as Japan, China, India, and South Korea. These countries represent a huge potential for various bone and joint reconstructive products because of the increasing patient pool suffering from various disorders and rising healthcare expenditure. 

 

The global regenerative medicine (bone and joint) market is segmented as follows:

  • Regenerative Medicine (Bone and Joint) Market, by Technology
    • Stem Cell Therapy
    • Biomaterial
    • Tissue Engineering
  • Regenerative Medicine (Bone and Joint) Market, by Application
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • Regenerative Medicine (Bone and Joint) Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

About Us


Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 


TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports. 

Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/global-regenerative-medicines-market.htm

About Us


Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

Contact


Mr.Sudip S 
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com